Menstrual migraine. Methods of prevention and control

Area of Science:

• Neurology
• Endocrinology
• Women's Health

Background:

• Migraine headaches in women often correlate with fluctuations in estrogen levels.
• Hormonal changes, particularly during the menstrual cycle, perimenopause, and menopause, significantly impact migraine incidence and severity.
• Estrogen's role is complex, with falling levels often triggering attacks while stable high levels may improve symptoms.

Purpose of the Study:

• To explore the relationship between estrogen levels and migraine headaches in women.
• To investigate the specific triggers for menstruation-associated migraine.
• To review treatment strategies for estrogen-related migraines.

Main Methods:

• Review of existing literature on hormonal influences on migraine.
• Analysis of clinical observations linking estrogen fluctuations to migraine patterns.
• Comparison of treatment efficacy for menstrual versus nonmenstrual migraines.

Main Results:

• Migraine incidence increases at menarche and attacks can be precipitated by premenstrual drops in estrogen.
• Symptoms often improve during pregnancy due to sustained high estrogen levels.
• Falling estradiol levels, not absolute levels, are identified as the primary trigger for menstruation-associated migraine.
• Migraine may improve after menopause when estrogen levels are consistently low but noncyclic.

Conclusions:

• Estrogen level fluctuations are a key factor in migraine pathophysiology for many women.
• Menstruation-associated migraine is triggered by a decline in estradiol.
• Acute treatment for menstrual migraine is comparable to nonmenstrual migraine, with Sumatriptan showing equal efficacy for both types.